Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc versus Kaletra with Truvada for HIV post-exposure prophylaxis
ISRCTN63350011Phase 4Completed
- Sponsor
- Central and North West London NHS Foundation Trust
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of maraviroc, lopinavir + ritonavir and emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Central and North West London NHS Foundation Trust. Started Dec 2011; status: completed.
02
Drugs
maraviroclopinavir + ritonaviremtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN63350011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63350011.